Description:

AMC-061 Adverse Events Form (ADV) NCT00890747 Sunitinib Malate in Treating HIV-Positive Patients With Cancer Undergoing Highly Active Antiretroviral Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=71988CF7-F8CE-68F0-E040-BB89AD4358A1

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=71988CF7-F8CE-68F0-E040-BB89AD4358A1

Keywords:
Versions (3) ▾
  1. 8/26/12
  2. 1/9/15
  3. 6/16/15
Uploaded on:

June 16, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

AMC-061 Adverse Events Form (ADV) NCT00890747

Based on information entered, an AdEERS Report must be submitted. Please go to the CTEP website and access the AdEERS system

Adverse Event Information
Was this event expected or anticipated
CTC Adverse Event Attribution Code
Alternative etiology
Action Taken at Time of Adverse Event
If modification was made to study therapy, who initiated modification
Outcome of Adverse Event
Was this considered a Serious Adverse Event
Seriousness Attributed to Adverse Event (If "Yes" check "Yes" for all that apply Please note that checking "Yes" to any of the events below will require SAE notification according to protocol requirements.)
Comments